Possible resurrection of build back better from the dead: drug price measures could be key component

Forbes

2 June 2022 - While a large Build Back Better bill was scuttled last winter, a substantially slimmed down version may still pass. 

And, this piece of legislation could contain prescription drug pricing stipulations designed to decrease government spending on pharmaceuticals and lower patients’ out of pocket costs.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing